IP Library Granted Patent US 10,934,580
Granted Patent B2
US 10,934,580 · App. 15/760,537 · Granted Mar 2, 2021

Molecular quality assurance methods for use in sequencing

Inventors: Samuel Aparicio (Vancouver, CA); Sohrab Shah (Vancouver, CA); Rosalia Aguirre-Hernandez (Vancouver, CA); Leah Prentice (Vancouver, CA); Patrick Franchini (Vancouver, CA); Jaswinder Singh Khattra (Vancouver, CA); Tong He (Vancouver, CA)
Assignee: CANEXIA HEALTH INC.
C12Q1/6851C12Q1/686C12Q1/6869G16B25/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,934,580
App. No.
15/760,537
Granted
Mar 2, 2021
Kind
B2
Abstract

The present invention relates to quality assurance methods for use in amplification techniques, such as Next Generation Sequencing (NGS).

Claims (18)

1. A method of determining the complexity of a nucleic acid template, or of identifying a true sequence variant, comprising:

i) providing a nucleic acid template;

ii) providing a plurality of primer pairs, comprising a first primer and a second primer, wherein the first primer comprises a sequence complementary to a portion of the nucleic acid template, and the second primer comprises a sequence complementary to a portion of the complement of the nucleic acid template;

iii) attaching a codeword to the 5′ end of the first primer, the 5′ end of the second primer, or both, to form a codeword-primer molecule, or to the nucleic acid template to form a codeword-template molecule;

iv) performing an amplification reaction with the paired codeword-primer molecules and the nucleic acid template or with the primer pairs and the codeword-template molecule for a defined number of cycles to obtain an amplification reaction product;

v) obtaining the sequence of the amplification reaction product at the end of each cycle, at the end of the defined number of cycles, or at an intermediate number of cycles;

vi) determining the abundance of each codeword present in the amplification reaction product at the end of each cycle, at the end of the defined number of cycles, or at an intermediate number of cycles;

vii) calculating an observed codeword entropy of each cycle after step vi); and

viii) comparing the observed codeword entropy to an estimated codeword entropy, to determine the complexity of the nucleic acid template; or

ix) performing a supervised classification method based on the results of steps vi) and vii), to identify the true sequence variant.

2. The method of claim 1 wherein the true sequence variant is a low prevalence sequence variant.

3. The method of claim 1 wherein the nucleic acid template is a DNA template.

4. The method of claim 1 wherein the codeword-primer molecule or the primer is further attached to an adapter sequence.

5. The method of claim 1 wherein a different codeword is attached to each primer in the primer pair or the same codeword is attached to each primer in the primer pair.

6. The method of claim 1 wherein the codewords are attached to the nucleic acid template at random.

7. The method of claim 1 wherein the observed codeword entropy is calculated by Shannon entropy, the Simpson index, or any other diversity index.

8. The method of claim 1 wherein the codewords are present in a non-uniform pool or are present in a balanced pool.

9. The method of claim 1 further comprising determining one or more of amplification process, contamination, sample identity mismatch, or codeword pool imbalance.

Assignments (4)
COURT APPOINTMENT Recorded Aug 7, 2024
From: CANEXIA HEALTH INC.
To: FTI CONSULTING CANADA INC.
Reel/Frame 068211/0457 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2024
From: FTI CONSULTING CANADA INC.
To: PACBRIDGE PARTNERS II INVESTMENT CO. LTD.
Reel/Frame 068211/0697 →
CHANGE OF NAME Recorded Nov 3, 2020
From: CONTEXTUAL GENOMICS INC.
To: CANEXIA HEALTH INC.
Reel/Frame 054256/0111 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2018
From: APARICIO, SAMUEL; SHAH, SOHRAB; AGUIRRE-HERNANDEZ, ROSALIA; PRENTICE, LEAH; FRANCHINI, PATRICK; KHATTRA, JASWINDER SINGH; HE, TONG
To: CONTEXTUAL GENOMICS INC.
Reel/Frame 045242/0190 →
Continuity (2)
Provisional Application 62233074 · Sep 25, 2015
Related Publication 20180258479A1 · Sep 13, 2018